大洋生物(003017.SZ):擬變更會計師事務所
格隆匯 12 月 7日丨大洋生物(003017.SZ)公佈,公司於2020年12月7日召開第四屆董事會第二十一次會議以及第四屆監事會第十四次會議,分別審議通過了《關於變更會計師事務所的議案》。公司擬將2020年度審計機構變更為中匯會計師事務所(特殊普通合夥)(“中匯所”或“中匯”)。該議案尚需提交公司股東大會審議。
公司原審計機構瑞華會計師事務所(特殊普通合夥)(“瑞華所”)已經連續多年為公司提供審計服務,在執業過程中遵循獨立、客觀、公正的執業準則,從會計專業角度維護了公司與全體股東的利益。
根據公司業務發展和未來審計的需要,經綜合評價,公司擬選聘中匯所為公司2020年度會計審計機構及內部控制審計機構,聘期一年,年度審計費用為人民幣捌拾萬元整,並提請股東大會審議及授權公司經營管理層簽訂審計協議。公司已就變更會計師事務所的事項與瑞華所進行了事先溝通。在此,公司對瑞華所多年來為公司提供的專業審計服務和辛勤工作表示誠摯的感謝。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.